Integer (ITGR) vs Neuraxis (NRXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuraxis (NRXS) has outperformed Integer (ITGR) over the past year, gaining 127.1% versus a gain of 22.0%. Integer is the larger company by market cap ($4.30 billion vs $84.4 million), about 51.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITGR | NRXS |
|---|---|---|
| Share price | $126.57 | $6.72 |
| Market cap | $4.30B | $84.39M |
| 1-day change | -0.02% | -1.61% |
| YTD return | +61.41% | +50.44% |
| 1-year return | +22.05% | +127.14% |
| 5-year return | +41.79% | — |
| P/E ratio (TTM) | 34.58 | — |
| Forward P/E | 18.43 | — |
| EPS (TTM) | $3.66 | $-0.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.85B | — |
| Revenue growth (YoY) | +7.98% | — |
| Net income (latest FY) | $102.81M | — |
| Gross margin | 26.99% | — |
| Operating margin | 11.94% | — |
| Net margin | 5.55% | — |
| 52-week high | $126.80 | $9.33 |
| 52-week low | $62.00 | $2.21 |
| Distance from 52-week high | -0.19% | -27.97% |
| Analyst consensus | none | — |
| Avg. price target upside | -3.76% | — |
| Average volume | 981.56K | 107.18K |
| Shares outstanding | 34.00M | 12.56M |
| Employees | 11,000 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Integer is about 51.0 times larger than Neuraxis by market value ($4.30B vs $84.39M).
- NRXS has outperformed ITGR by 105.1 percentage points over the past year.
About Integer
ITGR stock →Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 11,000 employees
ITGR vs NRXS FAQ
Which is bigger, Integer or Neuraxis?
Integer (ITGR) is larger, with a market capitalization of $4.30B compared with $84.39M for Neuraxis (NRXS).
Which stock has performed better over the past year, ITGR or NRXS?
NRXS returned +127.14% over the past 12 months, compared with +22.05% for ITGR (price return, excluding dividends). Past performance does not predict future results.
Are Integer and Neuraxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.